Editor's Choice – Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia
European Journal of Vascular and Endovascular Surgery · 2026
DOI: 10.1016/j.ejvs.2026.02.018 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026. Verfasst von Michael S Conte und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA. Electronic address: michael.conte2@uc…. Hauptthemen laut MEDLINE: Chronic Limb-Threatening Ischemia, Endovascular Procedures, Femoral Artery, Ischemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: NIDDK NIH HHS, Novo Nordisk Fonden, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
OBJECTIVE: Multiple options exist for the treatment of femoropopliteal (FP) disease, including endovascular interventions (ENDOs) and bypass surgery (OPEN). There are limited data directly comparing ENDO and OPEN strategies for FP disease in chronic limb threatening ischaemia (CLTI). METHODS: Outcomes of patients in the Best Endovascular vs. Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial who underwent revascularisation for FP disease were examined. ENDO and OPEN were compared using single segment great saphenous vein (SSGSV) or alternative conduits (ACs). The primary outcome was major adverse limb event (MALE) or death; secondary outcomes included major amputation (MA); major re-intervention; amputation free survival; any re-intervention, MA, or death (RAD); and any re-intervention. RESULTS: Seven hundred and sixty-four patients underwent ENDO (378), OPEN with SSGSV (265), or OPEN with AC (121) procedures for FP disease. Patients had a mean age of 67 years; 66.6% were men, and 75.9% were White. Comorbidities included hypertension (85.5%), hyperlipidaemia (75.4%), diabetes mellitus (59.5%), smoking (47.2%), coronary artery disease (40.4%), and end-stage renal disease (7.6%); 68.4% of patients had tissue loss. Wound, Ischemia, and foot Infection (WIfI) stages were stage 1 (7.3%), stage 2 (35.2%), stage 3 (28.4%), and stage 4 (29.1%). TASC II classification of the FP disease was A and B (24.0%), C (25.4%), D (34.8%), or not scored (15.8%). Associated (untreated) infrapopliteal disease was present in 42.5%. ENDO treatments included plain balloon angioplasty (9.3%), drug coated balloons (32%), drug eluting stents (24.9%), bare metal stents (55.6%), stent grafts (17.5%), and atherectomy (11.1%). Cox models demonstrated superior MALE and death, MA, RAD, major re-intervention, and any re-intervention for OPEN SSGSV vs. ENDO. OPEN SSGSV also demonstrated superior freedom from MALE and death, and greater amputation free survival vs. OPEN AC. Presence of infrapopliteal disease, tissue loss, TASC classification, and diabetes mellitus were significant covariables. CONCLUSION: Open FP bypass with an SSGSV conduit provides the most effective revascularisation for patients with CLTI due to advanced FP disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA. Electronic address: michael.conte2@ucsf.edu.
- Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
- Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA.
- Department of Vascular and Endovascular Surgery, The Permanente Medical Group, South San Francisco, CA, USA.
- School of Public Health, Boston University, Boston, MA, USA.
- Division of Cardiac and Vascular Surgery, Department of Surgery, Nova Scotia Health Association, Dalhousie University, Halifax, Nova Scotia, Canada.
Förderung
- NIDDK NIH HHS
- Novo Nordisk Fonden
- National Heart Lung and Blood Institute
Zitieren
APA
Conte, M. S., Farber, A., Liu, I. H., Chang, R. W., Doros, G., Herman, C. R., Hiramoto, J. S., McGinigle, K. L., Siracuse, J. J., Strong, M., & Menard, M. T. (2026). Editor's Choice – Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2026.02.018
Vancouver
Conte MS, Farber A, Liu IH, Chang RW, Doros G, Herman CR, et al. Editor's Choice – Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia. European Journal of Vascular and Endovascular Surgery. 2026. doi:10.1016/j.ejvs.2026.02.018
BibTeX
@article{Conte2026,
author = {Conte, Michael S and Farber, Alik and Liu, Iris H and Chang, Robert W and Doros, Gheorghe and Herman, Christine R and Hiramoto, Jade S and McGinigle, Katharine L and Siracuse, Jeffrey J and Strong, Michael and Menard, Matthew T},
title = {Editor's Choice – Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2026},
doi = {10.1016/j.ejvs.2026.02.018}
}
EUVIMED